Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies

doi:10.4252/wjsc.v11.i11.920

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (9989)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-6) series.

Item

Count

PDF

501

WORD

244

HTML

4738

Figures (1-3)

433

Tables (1-6)

291

Sum=6207

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

534

Download

1015

Sum=1549

Publishing Process of This Article

Item

Count

Browse

859

Download

1374

Sum=2233

Nov 26, 2019 (publication date) through Feb 21, 2025

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Stem Cells. Nov 26, 2019; 11(11): 920-936
Published online Nov 26, 2019. doi: 10.4252/wjsc.v11.i11.920

Table 3 Positive correlation between combined expression of cancer stem cell markers CD133, CD44 and CD166 and epigenetic erasers

Family/gene symbol	Putative epidrug/chemical probe	Z-score	P value
DNA demethylation
TET2	-	5.968	2.40E-09
Histone demethylation
LSD family of demethylases
	ORY-1001³, (±)-tranylcypromine³
KDM3B		5.636	1.74E-08
KDM4B	CP2³[90]	5.212	1.87E-07
KDM4C	CP2³[90]	3.895	9.81E-05
KDM5B	CPI-455³, AS-8351³, 59³ (KDOAMA-25³)[90]	9.092	9.72E-20
KDM6A	GSK-J1³	2.84	0.00451
KDM6B	GSK-J1³	4.014	5.98E-05

¹Approved for the treatment of other diseases; ²Used in clinical trials for other diseases;

³Not yet used in clinical trials.

Citation: Vincent A, Ouelkdite-Oumouchal A, Souidi M, Leclerc J, Neve B, Van Seuningen I. Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies. World J Stem Cells 2019; 11(11): 920-936
URL: https://www.wjgnet.com/1948-0210/full/v11/i11/920.htm
DOI: https://dx.doi.org/10.4252/wjsc.v11.i11.920